Meropenem-vaborbactam is among several FDA- and EMA-approved treatments for HAP and VAP. Others include ceftobiprole, ceftolozane-tazobactam, imipenem-relebactam, and cefiderocol. Iclaprim and aztreonam-avibactam are both promising treatments but currently lack approval from the FDA and EMA. Arbekacin has been shown effective in research from Japan but currently lacks approval.
Learn more about meropenem-vaborbactam.
Medscape © 2022 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Rapid Review Quiz: Hospital-Acquired Pneumonia - Medscape - Sep 15, 2022.